157 related articles for article (PubMed ID: 26786782)
21. Access to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: qualitative findings from health navigators with the iDU ("I do") Care Collaborative.
Stopka TJ; Hutcheson M; Donahue A
Harm Reduct J; 2017 May; 14(1):26. PubMed ID: 28521814
[TBL] [Abstract][Full Text] [Related]
22. Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African cities.
Scheibe A; Shelly S; Lambert A; Schneider A; Basson R; Medeiros N; Padayachee K; Savva H; Hausler H
Harm Reduct J; 2017 Jun; 14(1):35. PubMed ID: 28592246
[TBL] [Abstract][Full Text] [Related]
23. Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.
Tempalski B; Williams LD; West BS; Cooper HLF; Beane S; Ibragimov U; Friedman SR
Subst Abuse Treat Prev Policy; 2020 Jan; 15(1):3. PubMed ID: 31918733
[TBL] [Abstract][Full Text] [Related]
24. Syringe disposal among people who inject drugs before and after the implementation of a syringe services program.
Levine H; Bartholomew TS; Rea-Wilson V; Onugha J; Arriola DJ; Cardenas G; Forrest DW; Kral AH; Metsch LR; Spencer E; Tookes H
Drug Alcohol Depend; 2019 Sep; 202():13-17. PubMed ID: 31280002
[TBL] [Abstract][Full Text] [Related]
25. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
[TBL] [Abstract][Full Text] [Related]
26. Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009.
Topp L; Day CA; Iversen J; Wand H; Maher L;
AIDS; 2011 Mar; 25(6):835-42. PubMed ID: 21192232
[TBL] [Abstract][Full Text] [Related]
27. Drug-related stigma and access to care among people who inject drugs in Vietnam.
Lan CW; Lin C; Thanh DC; Li L
Drug Alcohol Rev; 2018 Mar; 37(3):333-339. PubMed ID: 28762584
[TBL] [Abstract][Full Text] [Related]
28. Service Utilization among Persons Who Inject Drugs Attending a Syringe Exchange Program in New York State.
Beidelman ET; Parker MA; Zoh RS; Owora AH
Subst Use Misuse; 2023; 58(5):649-656. PubMed ID: 36814373
[TBL] [Abstract][Full Text] [Related]
29. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.
Islam MM; Topp L; Iversen J; Day C; Conigrave KM; Maher L
Aust N Z J Public Health; 2013 Apr; 37(2):148-54. PubMed ID: 23551473
[TBL] [Abstract][Full Text] [Related]
30. Injecting on the Island: a qualitative exploration of the service needs of persons who inject drugs in Prince Edward Island, Canada.
McCutcheon JM; Morrison MA
Harm Reduct J; 2014 Mar; 11():10. PubMed ID: 24593319
[TBL] [Abstract][Full Text] [Related]
31. Syringe exchange programs --- United States, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1488-91. PubMed ID: 21085091
[TBL] [Abstract][Full Text] [Related]
32. Acceptability of supervised injection facilities among persons who inject drugs in upstate New York.
Duncan E; Shufelt S; Barranco M; Udo T
Harm Reduct J; 2022 Jul; 19(1):87. PubMed ID: 35907854
[TBL] [Abstract][Full Text] [Related]
33. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan.
Latypov A; Otiashvili D; Zule W
Int J Drug Policy; 2014 Nov; 25(6):1204-14. PubMed ID: 25449057
[TBL] [Abstract][Full Text] [Related]
34. Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.
O'Keefe D; Wilkinson A; Aitken C; Dietze P
PLoS One; 2018; 13(12):e0209280. PubMed ID: 30550588
[TBL] [Abstract][Full Text] [Related]
35. Correlates of disparities in syringe return ratios: A cross-sectional study of a syringe services program in New York.
Parker MA; Zoh RS; Nelson EJ; Owora AH
J Subst Abuse Treat; 2021 Feb; 121():108193. PubMed ID: 33357603
[TBL] [Abstract][Full Text] [Related]
36. Interest in Getting Help to Reduce or Stop Substance Use Among Syringe Exchange Clients Who Use Opioids.
Frost MC; Williams EC; Kingston S; Banta-Green CJ
J Addict Med; 2018; 12(6):428-434. PubMed ID: 29889118
[TBL] [Abstract][Full Text] [Related]
37. Social marketing of low dead space syringes in Vietnam: findings from a 1-year pilot program in Hanoi, Thai Nguyen, and Ho Chi Minh City.
Huong NT; Mundy G; Neukom J; Zule W; Tuan NM; Tam NM
Harm Reduct J; 2015 May; 12():15. PubMed ID: 26024921
[TBL] [Abstract][Full Text] [Related]
38. Correlates of public support toward federal funding for harm reduction strategies.
Kulesza M; Teachman BA; Werntz AJ; Gasser ML; Lindgren KP
Subst Abuse Treat Prev Policy; 2015 Jun; 10():25. PubMed ID: 26122408
[TBL] [Abstract][Full Text] [Related]
39. Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.
Deryabina A; El-Sadr WM
Drug Alcohol Depend; 2017 Oct; 179():180-186. PubMed ID: 28787695
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for loss to follow-up of persons who inject drugs enrolled at syringe services programs in Kentucky.
Soria J; Johnson T; Collins J; Corby-Lee G; Thacker J; White C; Hoven A; Thornton A
Int J Drug Policy; 2021 Sep; 95():103255. PubMed ID: 33853033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
